To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Transcriptional modulation unique to vulnerable motor neurons predicts ALS across species and SOD1 mutations
Stockholm University, Stockholm.
Stockholm University, Stockholm; Karolinska Institutet, Stockholm.
Stockholm University, Stockholm; Karolinska Institutet, Stockholm.
Karolinska Institutet, Stockholm.
Show others and affiliations
2025 (English)In: Genome Research, ISSN 1088-9051, E-ISSN 1549-5469, Vol. 35, no 9, p. 1975-1991Article in journal (Refereed) Published
Abstract [en]

Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of motor neurons (MNs) that innervate skeletal muscles. However, certain MN groups including ocular MNs, are relatively resilient. To reveal key drivers of resilience versus vulnerability in ALS, we investigate the transcriptional dynamics of four distinct MN populations in SOD1G93A ALS mice using LCM-seq and single molecule fluorescent in situ hybridization. We find that resilient ocular MNs regulate few genes in response to disease. Instead, they exhibit high baseline gene expression of neuroprotective factors including En1, Pvalb, Cd63 and Gal, some of which vulnerable MNs upregulate during disease. Vulnerable motor neuron groups upregulate both detrimental and regenerative responses to ALS and share pathway activation, indicating that breakdown occurs through similar mechanisms across vulnerable neurons, albeit with distinct timing. Meta-analysis across four rodent mutant SOD1 MN transcriptome datasets identify a shared vulnerability code of 39 genes including Atf4, Nupr1, Ddit3, and Penk, involved in apoptosis as well as proregenerative and anti-apoptotic signature consisting of Atf3, Vgf, Ina, Sprr1a, Fgf21, Gap43, Adcyap1, and Mt1 Machine learning using genes upregulated in SOD1G93A spinal MN predicts disease in human stem cell-derived SOD1E100G MNs, and shows that dysregulation of VGF, INA, and PENK are strong disease-predictors across species and SOD1 mutations. Our study reveals MN population-specific gene expression and temporal disease-induced regulation that together provide a basis to explain ALS selective vulnerability and resilience and that can be used to predict disease.

Place, publisher, year, edition, pages
Cold Spring Harbor Laboratory Press (CSHL), 2025. Vol. 35, no 9, p. 1975-1991
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:oru:diva-122803DOI: 10.1101/gr.279501.124ISI: 001563623100001PubMedID: 40675818Scopus ID: 2-s2.0-105014762496OAI: oai:DiVA.org:oru-122803DiVA, id: diva2:1990220
Funder
Ulla-Carin Lindquist Foundation for ALS-ResearchSwedish Research Council, 2016-02112Swedish Research Council, 2020-01049
Note

This work was supported by grants from the Swedish Research Council (2016-02112 and 2020-01049) to E.H.; the European Union Joint Programme for Neurodegenerative Disease (JPND) (529-2014-7500) to E.H.; the Department of Biochemistry and Biophysics, Stockholm University to E.H.; Ahlen's Foundation (ahlen-stiftelsen) to E.H.; the Ulla-Carin Lindquists Foundation for ALS research (Ulla-Carin Lindquists stiftelse foer ALS forskning) to E.H.; and Birgit Backmark's donation to ALS research at Karolinska Institute (Birgit Backmark's Donation till ALS forskning vid Karolinska Institutet) to E.H. I.L. has been financed by a MESR ("French ministry for high education and research") PhD fellowship. Project-related funding for C.S.L. comes from the French National ALS Association ("Association pour la recherche sur la SLA-ARSLA") and additional ALS associations ("Aide a la Recherche des Maladies du Cerveau-ARMC," and "SLA Fondation Recherche-SLAFR"). C.S.L. thanks the staff of the animal housing facility UMS28/CEF (Paris, France) and of the iGenSeq platform for genotyping (ICM, Paris, France, which received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06).

Available from: 2025-08-19 Created: 2025-08-19 Last updated: 2026-01-23Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Repsilber, Dirk

Search in DiVA

By author/editor
Repsilber, Dirk
By organisation
School of Medical Sciences
In the same journal
Genome Research
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 26 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf